Toripalimab Used on the Same Day or Third Day With Chemotherapy for Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study
Wenqun Xing(Zhengzhou University), Quanli Gao(Zhengzhou University), Xiaofei Chai(First Affiliated Hospital of Zhengzhou University), Zibing Wang(Huazhong University of Science and Technology), Baozhen Ma(Henan Cancer Hospital), Tiepeng Li(East China Normal University), Xiaomin Fu(Zhengzhou University), Jinrong Qu(Memorial Sloan Kettering Cancer Center), Lingdi Zhao(Zhengzhou University), Hongwei Lin(Zhengzhou University), Yonghao Yang(Army Medical University), Liang Liu(Baoding People's Hospital), Yong Zhang(Zhengzhou University), He Zhang(North University of China), Xiubao Ren(Tianjin Medical University Cancer Institute and Hospital), Dongfeng Yuan(Shandong University), Jiangong Zhang(Northwestern Polytechnic University), Baoxing Liu(Henan Cancer Hospital), Guanghui Liang(Zhengzhou University), Xianben Liu(Zhengzhou University), Yan Zheng(First Affiliated Hospital of Xi'an Jiaotong University), Yiman Shang(Henan Cancer Hospital)
Cited by 0
Related Papers
A reference panel of 64,976 haplotypes for genotype imputation
|Nature Genetics|2016|3.3k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
|JAMA|2024|359
Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease
|Journal of the American College of Cardiology|2017|270
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma
|British Journal of Haematology|2021|217